Merck KGaA - Asset Resilience Ratio

Latest as of December 2025: 1.15%

Merck KGaA (MRK) has an Asset Resilience Ratio of 1.15% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check how strategically is Merck KGaA's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets

€597.00 Million

≈ $697.96 Million USD Cash + Short-term Investments

Total Assets

€52.10 Billion

≈ $60.91 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2005–2025)

This chart shows how Merck KGaA's Asset Resilience Ratio has changed over time. See MRK net asset quality score to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Merck KGaA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Merck KGaA worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€597.00 Million	1.15%
Total Liquid Assets	€597.00 Million	1.15%

Asset Resilience Insights

Limited Liquidity: Merck KGaA maintains only 1.15% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Merck KGaA Industry Peers by Asset Resilience Ratio

Compare Merck KGaA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Aurobindo Pharma Limited NSE:AUROPHARMA	Drug Manufacturers - Specialty & Generic	1.28%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Tianjin Chase Sun Pharmaceutical Co Ltd SHE:300026	Drug Manufacturers - Specialty & Generic	-0.89%
Zhejiang Hisoar Pharmaceutical Co Ltd SHE:002099	Drug Manufacturers - Specialty & Generic	0.20%
Xeris Pharmaceuticals Inc NASDAQ:XERS	Drug Manufacturers - Specialty & Generic	0.00%
Procter & Gamble Health Limited NSE:PGHL	Drug Manufacturers - Specialty & Generic	33.01%

Annual Asset Resilience Ratio for Merck KGaA (2005–2025)

The table below shows the annual Asset Resilience Ratio data for Merck KGaA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	1.15%	€597.00 Million ≈ $697.96 Million	€52.10 Billion ≈ $60.91 Billion	+0.06pp
2024-12-31	1.08%	€558.00 Million ≈ $652.36 Million	€51.57 Billion ≈ $60.29 Billion	+0.61pp
2023-12-31	0.48%	€231.00 Million ≈ $270.06 Million	€48.49 Billion ≈ $56.70 Billion	-0.03pp
2022-12-31	0.50%	€244.00 Million ≈ $285.26 Million	€48.53 Billion ≈ $56.73 Billion	+0.26pp
2021-12-31	0.25%	€112.00 Million ≈ $130.94 Million	€45.36 Billion ≈ $53.03 Billion	+0.18pp
2020-12-31	0.07%	€29.00 Million ≈ $33.90 Million	€41.80 Billion ≈ $48.86 Billion	+0.00pp
2019-12-31	0.07%	€29.00 Million ≈ $33.90 Million	€43.81 Billion ≈ $51.22 Billion	+0.04pp
2018-12-31	0.02%	€8.00 Million ≈ $9.35 Million	€36.89 Billion ≈ $43.13 Billion	-0.08pp
2017-12-31	0.10%	€35.00 Million ≈ $40.92 Million	€35.62 Billion ≈ $41.64 Billion	-0.01pp
2016-12-31	0.11%	€43.00 Million ≈ $50.27 Million	€38.25 Billion ≈ $44.72 Billion	-0.39pp
2015-12-31	0.50%	€191.40 Million ≈ $223.77 Million	€38.01 Billion ≈ $44.43 Billion	-7.79pp
2014-12-31	8.29%	€2.16 Billion ≈ $2.52 Billion	€26.01 Billion ≈ $30.41 Billion	-3.07pp
2013-12-31	11.36%	€2.37 Billion ≈ $2.77 Billion	€20.82 Billion ≈ $24.34 Billion	+4.06pp
2012-12-31	7.30%	€1.58 Billion ≈ $1.85 Billion	€21.64 Billion ≈ $25.30 Billion	+2.25pp
2011-12-31	5.05%	€1.12 Billion ≈ $1.31 Billion	€22.12 Billion ≈ $25.86 Billion	+4.80pp
2010-12-31	0.25%	€55.60 Million ≈ $65.00 Million	€22.39 Billion ≈ $26.17 Billion	-8.75pp
2009-12-31	8.99%	€1.50 Billion ≈ $1.76 Billion	€16.71 Billion ≈ $19.54 Billion	+7.86pp
2008-12-31	1.13%	€176.80 Million ≈ $206.70 Million	€15.64 Billion ≈ $18.29 Billion	-2.66pp
2007-12-31	3.79%	€565.30 Million ≈ $660.90 Million	€14.92 Billion ≈ $17.45 Billion	+2.15pp
2006-12-31	1.64%	€133.10 Million ≈ $155.61 Million	€8.10 Billion ≈ $9.47 Billion	-0.48pp
2005-12-31	2.12%	€154.20 Million ≈ $180.28 Million	€7.28 Billion ≈ $8.51 Billion	--

pp = percentage points

About Merck KGaA

XETRA:MRK Germany Drug Manufacturers - Specialty & Generic

Market Cap

$19.95 Billion

€17.07 Billion EUR

Market Cap Rank

#1311 Global

#288 in Germany

Share Price

€132.05

Change (1 day)

-0.49%

52-Week Range

€102.80 - €139.50

All Time High

€220.61